Genetic Variation Determines Mast Cell Functions in Experimental Asthma
暂无分享,去创建一个
H. Schild | B. Echtenacher | E. Schmitt | S. Reuter | C. Taube | M. Klein | T. Bopp | M. Becker | M. Stassen | M. Radsak | Fatma Doener | Pamela Friedrich | Anastasija Michel | F. Doener
[1] P. Foster,et al. New insights into the generation of Th2 immunity and potential therapeutic targets for the treatment of asthma , 2011, Current opinion in allergy and clinical immunology.
[2] William W. Busse,et al. Asthma: Clinical expression and molecular mechanisms , 2010, Journal of Allergy and Clinical Immunology.
[3] S. Sudowe,et al. Mast Cells Induce Migration of Dendritic Cells in a Murine Model of Acute Allergic Airway Disease , 2009, International Archives of Allergy and Immunology.
[4] E. Gelfand,et al. Understanding asthma using animal models , 2009, Allergy, asthma & immunology research.
[5] K. Austen,et al. Innate cells and T helper 2 cell immunity in airway inflammation. , 2009, Immunity.
[6] H. Schild,et al. Impaired Mast Cell-Driven Immune Responses in Mice Lacking the Transcription Factor NFATc21 , 2009, The Journal of Immunology.
[7] C. Benoist,et al. Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. , 2008, The American journal of pathology.
[8] F. Ducharme,et al. Inhaled sodium cromoglycate for asthma in children. , 2008, The Cochrane database of systematic reviews.
[9] C. Taube,et al. Advances in the understanding of mast cell function , 2008, British journal of haematology.
[10] A. August,et al. Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma , 2008, The Journal of experimental medicine.
[11] S. Reuter,et al. Mast cell-derived tumour necrosis factor is essential for allergic airway disease , 2008, European Respiratory Journal.
[12] H. Schild,et al. Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice. , 2007, Blood.
[13] J. Ryan,et al. Cutting Edge: Genetic Variation Influences FcεRI-Induced Mast Cell Activation and Allergic Responses1 , 2007, The Journal of Immunology.
[14] S. Galli,et al. Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice. , 2007, The Journal of allergy and clinical immunology.
[15] P. Bradding. Mast cell regulation of airway smooth muscle function in asthma , 2007, European Respiratory Journal.
[16] C. Brightling,et al. The reclassification of asthma based on subphenotypes , 2007, Current opinion in allergy and clinical immunology.
[17] K. Manova,et al. A Distant Upstream Locus Control Region Is Critical for Expression of the Kit Receptor Gene in Mast Cells , 2006, Molecular and Cellular Biology.
[18] S. Holgate,et al. The role of the mast cell in the pathophysiology of asthma. , 2006, The Journal of allergy and clinical immunology.
[19] J. Zehnder,et al. Mast cells can promote the development of multiple features of chronic asthma in mice. , 2006, The Journal of clinical investigation.
[20] R. Keren,et al. Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma. , 2006, The Cochrane database of systematic reviews.
[21] Y. Kohno,et al. Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[22] U. Yamashita,et al. Strain difference of murine bone marrow‐derived mast cell functions , 2005, Journal of leukocyte biology.
[23] C. Chen,et al. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. , 2005, The American journal of pathology.
[24] J. Bousquet,et al. The effect of treatment with omalizumab, an anti‐IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma , 2005, Allergy.
[25] P. Wolters,et al. Tissue‐selective mast cell reconstitution and differential lung gene expression in mast cell‐deficient KitW‐sh/KitW‐sh sash mice , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[26] S. Orkin,et al. A Critical Role for Eosinophils in Allergic Airways Remodeling , 2004, Science.
[27] E. Lenkiewicz,et al. Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils , 2004, Science.
[28] Stephen T Holgate,et al. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. , 2004, American journal of respiratory and critical care medicine.
[29] Xudong Wei,et al. Mast Cells, FcεRI, and IL-13 Are Required for Development of Airway Hyperresponsiveness after Aerosolized Allergen Exposure in the Absence of Adjuvant1 , 2004, The Journal of Immunology.
[30] D. Schwartz,et al. Allergen-induced airway disease is mouse strain dependent. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[31] P. Foster,et al. Intrinsic Defect in T Cell Production of Interleukin (IL)-13 in the Absence of Both IL-5 and Eotaxin Precludes the Development of Eosinophilia and Airways Hyperreactivity in Experimental Asthma , 2002, The Journal of experimental medicine.
[32] S. Galli,et al. Mast Cells Can Amplify Airway Reactivity and Features of Chronic Inflammation in an Asthma Model in Mice , 2000, The Journal of experimental medicine.
[33] T. Morokata,et al. C57BL/6 mice are more susceptible to antigen‐induced pulmonary eosinophilia than BALB/c mice, irrespective of systemic T helper 1/T helper 2 responses , 1999, Immunology.
[34] A. Zelenetz,et al. The W(sh), W(57), and Ph Kit expression mutations define tissue-specific control elements located between -23 and -154 kb upstream of Kit. , 1999, Blood.
[35] A. Kisselgof,et al. Genetic variability in pulmonary physiological, cellular, and antibody responses to antigen in mice. , 1999, American journal of respiratory and critical care medicine.
[36] E. Gelfand,et al. Development of Eosinophilic Airway Inflammation and Airway Hyperresponsiveness in Mast Cell–deficient Mice , 1997, The Journal of experimental medicine.
[37] A. Zelenetz,et al. The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[38] A. Zelenetz,et al. W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis. , 1993, Development.
[39] S. Nishikawa,et al. Exon skipping by mutation of an authentic splice site of c-kit gene in W/W mouse. , 1991, Nucleic acids research.
[40] K. Nocka,et al. Molecular bases of dominant negative and loss of function mutations at the murine c‐kit/white spotting locus: W37, Wv, W41 and W. , 1990, The EMBO journal.
[41] D. Housman,et al. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene , 1988, Cell.
[42] Y. Kitamura,et al. Genetically mast-cell-deficient W/Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. , 1987, The American journal of pathology.
[43] M. Lyon,et al. A new allele sash (Wsh) at the W-locus and a spontaneous recessive lethal in mice. , 1982, Genetical research.
[44] J. Alcorn,et al. Strain-dependent activation of NF-kappaB in the airway epithelium and its role in allergic airway inflammation. , 2010, American journal of physiology. Lung cellular and molecular physiology.
[45] J. Ryan,et al. Cutting edge: genetic variation influences Fc epsilonRI-induced mast cell activation and allergic responses. , 2007, Journal of immunology.
[46] K. Austen,et al. No audible wheezing : nuggets and conundrums from mouse asthma models , 2005 .
[47] M. Wills-Karp. Immunologic basis of antigen-induced airway hyperresponsiveness. , 1999, Annual review of immunology.